📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). (2015)

First Author: Deacon J

Attributed to: New strategies for the inhibition of Infection and Inflammation in Cystic Fibrosis Lung Disease funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2014.11.022

PubMed Identifier: 25481442

Publication URI: http://europepmc.org/abstract/MED/25481442

Type: Journal Article/Review

Volume: 198

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659